找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Lung Cancer:; Prevention, Manageme David J. Stewart Book 2010 Humana Press 2010 Antiangiogenesis.Cancer.Carcinom.Clinical trials.Lung.Malig

[復(fù)制鏈接]
樓主: AMASS
41#
發(fā)表于 2025-3-28 17:21:38 | 只看該作者
Chemoradiotherapy for Inoperable Non-small Cell Lung Cancer,eceptor and HER2/neu. It is anticipated that several other classes of new targeted agents could also play a role in the future. New radiotherapy techniques including intensity-modulated radiation therapy and proton beam therapy have the potential to further improve the outcome, and early clinical tr
42#
發(fā)表于 2025-3-28 21:35:07 | 只看該作者
Epidermal Growth Factor Receptor Inhibitors in the Treatment of Non-small Cell Lung Cancer,se trials. Novel TKIs may have the ability to overcome resistance to first generation TKI therapy. Furthermore, there are encouraging studies combining EGFR inhibitors and anti-angiogenesis drugs such as bevacizumab..In conclusion, EGFR inhibition, by a range of strategies, remains a central node in
43#
發(fā)表于 2025-3-28 23:18:30 | 只看該作者
Lung Cancer Resistance to Chemotherapy, transporters or cell membrane characteristics, increased drug efflux or detoxification, decreased drug binding, altered drug targets, increased DNA repair, decreased proapoptotic factors, increased antiapoptotic factors, altered cell cycling or mitotic checkpoints, or altered transcription factors.
44#
發(fā)表于 2025-3-29 05:50:25 | 只看該作者
45#
發(fā)表于 2025-3-29 09:20:08 | 只看該作者
Mesothelioma,of proto-oncogene expression. MPM is predominantly a locoregional, diffuse, aggressive disease with median survival of 9-17 months regardless of the stage of the disease. Multimodality therapy is becoming the standard treatment for resectable MPM. Extrapleural pneumonectomy (EPP) and pleurectomy/dec
46#
發(fā)表于 2025-3-29 11:23:22 | 只看該作者
Book 2010owth, advanced stage at diagnosis (due to nonspecificity of early sy- toms and the uncertain efficacy of screening), early development of metastases, and resistance to therapy. Several chapters in this book discuss new molecular targets that may be potentially exploitable in the future, as well as d
47#
發(fā)表于 2025-3-29 19:36:57 | 只看該作者
48#
發(fā)表于 2025-3-29 21:46:59 | 只看該作者
49#
發(fā)表于 2025-3-30 02:21:19 | 只看該作者
Alejandro Corvalan,Ignacio I. Wistubamize quantitative element analysis.Reviews a broad variety oThis book is a comprehensive source of the fundamentals, process parameters, instrumental components and applications of laser-induced breakdown spectroscopy (LIBS). The effect of multiple pulses on material ablation, plasma dynamics and pl
50#
發(fā)表于 2025-3-30 08:07:26 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 20:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
无为县| 安宁市| 宿迁市| 商城县| 延庆县| 平江县| 濮阳市| 庆云县| 淄博市| 平遥县| 自治县| 米脂县| 新田县| 依兰县| 宁蒗| 都江堰市| 美姑县| 泰安市| 台中市| 新田县| 陵水| 揭阳市| 邹城市| 汾阳市| 英德市| 修文县| 枣强县| 原阳县| 苗栗市| 绥芬河市| 治多县| 漾濞| 天峻县| 贞丰县| 奉节县| 齐齐哈尔市| 泸定县| 江孜县| 土默特右旗| 赤城县| 浮梁县|